Annals of the ICRP
Volume 38, Issue 1 , Pages 35-49 , February 2008

Annexes A and B

  • ICRP

      Affiliations

    • Corresponding Author InformationTel.: +46 8 729 7275; fax: +46 8 729 7298.

A.10. References for Annex A 

  1. Atkins, H.L., Cloutier, R.J., Lathrop, K.A. et al., 1975. Technetium-99m-sulfur colloid in various liver conditions. MIRD Dose Estimate Report No. 3. J. Nucl. Med. 16, 108A–108B.
  2. Bouchet LG, Bolch WE, Howell RW, Rao DV. S values for radionuclides localized within the skeleton. J. Nucl. Med. 2000;41:189–212
  3. Brown PH, Krishnamurthy GT, Bobba VR, Kingston E. Radiation-dose calculation for Tc-99m HIDA in health and disease. J. Nucl. Med. 1981;22:177–183
  4. Brown PH, Krishnamurthy GT, Bobba VR, Kingston E, Turner FE. Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. J. Nucl. Med. 1982;23:1025–1030
  5. Cloutier, R.J., Freeman, L.M., McAfee, J.G. et al., 1975. Summary of current radiation dose estimates to humans with various liver conditions from 198Au colloidal gold. MIRD Dose Estimate Report No. 4. J. Nucl. Med. 16, 173–174.
  6. Cristy M, Eckerman K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. Oak Ridge, TN: Oak Ridge National Laboratory; 1987;
  7. Eckerman KF, Stabin MG. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal region. Health Phys. 2000;78:199–214
  8. Gössner W, Masse R, Stather JW. Cells at risk for dosimetric modelling relevant to bone tumour induction. Radiat. Prot. Dosim. 2000;92:209–213
  9. Groshar D, Slobodin G, Zuckerman E. Quantitation of liver and spleen uptake of 99mTc-phytate colloid using SPECT: detection of liver cirrhosis. J. Nucl. Med. 2002;43:312–317
  10. Herzog H, Spohr G, Notohamiprodjo G, Feinendegen LE. Absolute quantification of pharmacokinetic distribution of RES colloids in individuals with normal liver function. Nucl. Med. Commun. 1987;8:157–175
  11. ICRP, 1975. Report of the Task Group on Reference Man. ICRP Publication 23. Pergamon Press, Oxford.
  12. ICRP, 1979. Limits for intakes of radionuclides by workers. ICRP Publication 30, Part 1. Ann. ICRP 2(3/4).
  13. ICRP, 1991a. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21(1–3).
  14. ICRP, 2002. Basic anatomical and physiological data for use in radiological protection: reference values. ICRP Publication 89. Ann. ICRP 31(3/4).
  15. ICRP, 2006. Human alimentary tract model for radiological protection. ICRP Publication 100. Ann. ICRP 35(1/2).
  16. Johansson L. Absorbed dose in the salivary glands from technetium-99m labeled radiopharmaceuticals. In:  Schlafke-Stelson A,  Stabin MG,  Sparks RB editor. Sixth International Radiopharmaceutical Dosimetry Symposium. Gatlinburg, TN: Oak Ridge Institute for Science and Education; 1996;p. 513–521
  17. Leggett RW, Williams LR. Suggested reference values for regional blood volumes in humans. Health Phys. 1991;60:139–154
  18. Leggett RW, Williams LR. A proposed blood circulation model for reference man. Health Phys. 1995;69:187–201
  19. Ryan J, Cooper M, Loberg M, Harvey E, Sikorski S. Technetium-99m-labelled N-(2,6-dimethylphenyl carbamoylmethyl)-iminodiacetic acid (Tc99mHIDA): a new radiopharmaceutical for hepatobiliary imaging studies. J. Nucl. Med. 1977;18:997–1004
  20. Smith T, Veall N, Wootton R. Bladder wall dose from administered radiopharmaceuticals: the effect of variation in urine flow rate, voiding interval and initial bladder content. Radiat. Prot. Dosim. 1982;2:183–189
  21. Snyder, W.S., Ford, M.R., 1976. Estimation of doses to the urinary bladder and to the gonads, in: Cloutier, R.J., Coffey, J.L., Snyder, W.S., et al. (Eds.), Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN. HEW Publication (FDA 76-8044). Department of Health, Education and Welfare, Bureau of Radiological Health, Rockville, MD, pp. 313–349.
  22. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med. 1996;37:538–546
  23. Stabin MG, Siegel JA. Physical models and dose factors for use in internal dose assessment. Health Phys. 2003;83:294–310
  24. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med. 2005;46:1023–1027
  25. Syed, I.B., 1976. Dosimetry of indium-113m radiopharmaceuticals with special attention to the urinary bladder, in: Cloutier, R.J., Coffey, J.L., Snyder, W.S., et al. (Eds.), Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN. HEW Publication (FDA 76-8044). Department of Health, Education and Welfare, Bureau of Radiological Health, Rockville, MD, pp. 360–369.
  26. Taavitsainen M, Riihimäki E, Tähti E. Body disappearance and liver mean transit time of 99m-Tc-diethyl-IDA. Eur. J. Nucl. Med. 1980;5:147–150
  27. Thomas, S.R., Stabin, M.G., Chen, C.-T., Samaratunga, R.C., 1999. A dynamic urinary bladder model for radiation dose calculations. MIRD Pamphlet No. 14, revised. J. Nucl. Med. 40, 102S–123S.
  28. Williams LR, Leggett RW. Reference values for resting blood flow to organs of man. Clin. Phys. Physiol. Meas. 1989;10:187–217
  29. Wistow BW, Subramanian G, Van Heertum RL, et al. An evaluation on 99mTc-labeled hepatobiliary agents. J. Nucl. Med. 1977;18:455–461
  30. Wu RK, Siegel JA, Rattner Z, Malmud LS. Tc-99m HIDA dosimetry in patients with various hepatic disorders. J. Nucl. Med. 1984;25:905–912

PII: S0146-6453(08)00040-7

doi: 10.1016/j.icrp.2008.08.004

Annals of the ICRP
Volume 38, Issue 1 , Pages 35-49 , February 2008

Article Tools

* Image Usage & Resolution